Dietary fructooligosaccharides and potential benefits on health.
Study Design
- Study Type
- Review
- Population
- healthy subjects
- Intervention
- Dietary fructooligosaccharides and potential benefits on health. 15 g/d
- Comparator
- None
- Primary Outcome
- cholesterol
- Effect Direction
- Mixed
- Risk of Bias
- Unclear
Abstract
Fructooligosaccharides (FOS) are oligosaccharides that occur naturally in plants such as onion, chicory, garlic, asparagus, banana, artichoke, among many others. They are composed of linear chains of fructose units, linked by beta (2-1) bonds. The number of fructose units ranges from 2 to 60 and often terminate in a glucose unit. Dietary FOS are not hydrolyzed by small intestinal glycosidases and reach the cecum structurally unchanged. There, they are metabolized by the intestinal microflora to form short-chain carboxylic acids, L -lactate, CO(2), hydrogen and other metabolites. FOS have a number of interesting properties, including a low sweetness intensity; they are also calorie free, non-cariogenic and are considered as soluble dietary fibre. Furthermore, FOS have important beneficial physiological effects such as low carcinogenicity, a prebiotic effect, improved mineral absorption and decreased levels of serum cholesterol, triacylglycerols and phospholipids. Currently FOS are increasingly included in food products and infant formulas due to their prebiotic effect stimulate the growth of nonpathogenic intestinal microflora. Their consumption increases fecal bolus and the frequency of depositions, while a dose of 4-15 g/day given to healthy subjects will reduce constipation, considered one of the growing problems of modern society, and newborns during the first months of life.
TL;DR
Their consumption increases fecal bolus and the frequency of depositions, while a dose of 4–15 g/day given to healthy subjects will reduce constipation, considered one of the growing problems of modern society, and newborns during the first months of life.
Used In Evidence Reviews
Similar Papers
Journal of the Academy of Nutrition and Dietetics · 2017
Understanding the Physics of Functional Fibers in the Gastrointestinal Tract: An Evidence-Based Approach to Resolving Enduring Misconceptions about Insoluble and Soluble Fiber.
The American journal of clinical nutrition · 2000
Efficacy, safety, and tolerability of fructooligosaccharides in the treatment of irritable bowel syndrome.
Neurogastroenterology and motility · 2017
Effects of scFOS on the composition of fecal microbiota and anxiety in patients with irritable bowel syndrome: a randomized, double blind, placebo controlled study.
The British journal of nutrition · 2003
Effects of fructo-oligosaccharide-supplemented infant cereal: a double-blind, randomized trial.
Journal of the American Medical Directors Association · 2007
Constipation in long-term care.
Nutrients · 2020